<unk>  is an antipsychotic that is FDA approved for the treatment of schizophrenic patients who fail to respond adequately to treatment with other antipsychotic drugs. There is a Black Box Warning for this drug as shown here.  Common adverse reactions include hypotension, orthostatic hypotension, diminished sweating, constipation, xerostomia, akathisia, dizziness, dystonia, extrapyramidal disease, parkinsonian, somnolence, tardive dyskinesia, blurred vision, epithelial keratopathy, retinitis pigmentosa, urinary retention and nasal congestion.
Thioridazine hydrochloride
Domperidone
Valproate sodium
Primidone
Deutetrabenazine
Rimonabant
Bedaquiline fumarate
Tetrabenazine